114 related articles for article (PubMed ID: 1364936)
21. Naproxen tolerability in the elderly: a summary report.
Geczy M; Peltier L; Wolbach R
J Rheumatol; 1987 Apr; 14(2):348-54. PubMed ID: 3599004
[TBL] [Abstract][Full Text] [Related]
22. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
[TBL] [Abstract][Full Text] [Related]
23. Enteric coated naproxen tablets.
Gamst ON
Eur J Rheumatol Inflamm; 1992; 12(2):5-8. PubMed ID: 1364940
[TBL] [Abstract][Full Text] [Related]
24. A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis.
Lohmander LS; McKeith D; Svensson O; Malmenäs M; Bolin L; Kalla A; Genti G; Szechinski J; Ramos-Remus C;
Ann Rheum Dis; 2005 Mar; 64(3):449-56. PubMed ID: 15345500
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerance of naproxen versus pirprofen in the treatment of patients with osteoarthritis.
Boussina I; Vischer TL
Pharmatherapeutica; 1987; 5(1):16-20. PubMed ID: 3602020
[TBL] [Abstract][Full Text] [Related]
26. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of diflunisal versus naproxen in osteoarthritis of the knee: an open study.
Deal CL; Moskowitz RW
Clin Ther; 1986; 9 Suppl C():1-14. PubMed ID: 3548982
[TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy and tolerability of two diclofenac formulations in the treatment of painful osteoarthritis.
Bakshi R
Br J Clin Pract; 1996 Sep; 50(6):294-7. PubMed ID: 8983316
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of the efficacy and toxicity of etodolac and naproxen in the treatment of osteoarthritis.
Chikanza IC; Clarke B; Hopkins R; MacFarlane DG; Bird H; Grahame R
Br J Clin Pract; 1994; 48(2):67-9. PubMed ID: 8024992
[TBL] [Abstract][Full Text] [Related]
31. Steady-state pharmacokinetics of enteric-coated naproxen tablets compared with standard naproxen tablets.
Jung D; Schwartz KE
Clin Ther; 1994; 16(6):923-9. PubMed ID: 7697688
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy and tolerance of Proxen 500 mg film-coated tablets in coxarthrosis].
Hawel R
Wien Med Wochenschr; 1983 Nov; 133(22):583-6. PubMed ID: 6666161
[TBL] [Abstract][Full Text] [Related]
33. Diclofenac/misoprostol: the European clinical experience.
McKenna F
J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the gastrointestinal side effects of naproxen formulated as plain tablets, enteric-coated tablets, or enteric-coated granules in capsules.
Aabakken L; Bjørnbeth BA; Hofstad B; Olaussen B; Larsen S; Osnes M
Scand J Gastroenterol Suppl; 1989; 163():65-73. PubMed ID: 2814364
[TBL] [Abstract][Full Text] [Related]
35. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee.
Schiff M; Minic M
J Rheumatol; 2004 Jul; 31(7):1373-83. PubMed ID: 15229960
[TBL] [Abstract][Full Text] [Related]
37. Open-label tolerability study of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis.
Bellamy N; Beaulieu A; Bombardier C; Esdaile J; Huang S; Jovaisas AV; Khanna VN; Kraag G; Mehta DM; Ménard HA
Curr Med Res Opin; 1992; 12(10):652-61. PubMed ID: 1633723
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
Karlsson J; Pivodic A; Aguirre D; Schnitzer TJ
J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
[TBL] [Abstract][Full Text] [Related]
39. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
[TBL] [Abstract][Full Text] [Related]
40. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
Vorsanger G; Xiang J; Jordan D; Farrell J
Clin Ther; 2007; 29 Suppl():2520-35. PubMed ID: 18164919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
